Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Rare Disease Diagnostics Market, and What Factors Will Drive It?

In the past few years, the size of the rare disease diagnostics market has seen robust growth. Its expansion is set to continue, from $35.23 billion in 2024 to $38.14 billion in 2025, with an 8.3% compound annual growth rate (CAGR). The historical progression is believed to arise from an elevated demand for cloud-based diagnostics, a more significant focus on enhancing efficiency, a growing occurrence of neurological diseases, a rise in immunological disorders, and increased expenditure in healthcare.

The market for rare disease diagnostics is forecasted to experience swift expansion in the coming years, with projections placing the market size at $56.08 billion in 2029 with a compound annual growth rate (CAGR) of 10.1%. The projected growth in this period is driven by various factors such as the growing prevalence of rare diseases, increased government interventions, an upsurge in the number of hospitals and diagnostic laboratories, the escalation of hematology diseases, and the development of healthcare infrastructure. The upcoming period will likely see major trends like advancements in genetic testing technologies, the roll-out of whole-genome sequencing and next-generation sequencing (NGS), substantial financial investments, and strategic partnerships for research projects.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12651&type=smp

What External and Internal Drivers Are Contributing to the Growth of theRare Disease Diagnostics Market?

The growing prevalence of rare diseases is anticipated to spur the expansion of the rare disease diagnostics market. Rare diseases are defined as health conditions with low frequency that impact a very small segment of the population compared to other more prevalent diseases. Donating diagnosis of such rare diseases facilitates enhanced disease management, determining prospective therapies, and avoiding unneeded treatments which may result in grave side effects, thus forming the basis for effective treatment. For example, as per Health Match, a digital health enterprise based in Australia, in November 2022, there are about 150 different rare kidney disorders, and these afflictions are quite common globally, with incidences ranging from 60–80 per 100,000 people in America and Europe. Consequently, the escalating prevalence of such rare diseases is fuelling the expansion of the rare disease diagnostics market.

What Segment Types Define the Rare Disease Diagnostics Market Structure?

The rare disease diagnosticsmarket covered in this report is segmented –

1) By Test Type: Genetic Test; General Lab Test; Imaging Test

2) By Technology: Capillary Sequencing; Whole Genome Sequencing; Whole Exome Sequencing; Microarrays

3) By Sample Type: Deoxyribonucleic Acid (DNA) Sample; Buccal Swab Sample; Blood; Saliva

4) By Disease Type: Gastroenterology Disease; Endocrine And Metabolism Disorders Disease; Hematology And Oncology Disease; Dermatology Disease; Cardiovascular Disorders; Neurology Disease

5) By End User: Hospital Laboratories; Diagnostics Laboratories; Genetic Testing Laboratories; Cancer Research Laboratories

Subsegments:

1) By Genetic Test: Whole Genome Sequencing; Targeted Gene Panels; Exome Sequencing; Carrier Testing

2) By General Lab Test: Blood Tests; Biochemical Assays; Urine Tests; Cytogenetic Tests

3) By Imaging Test: MRI (Magnetic Resonance Imaging); CT (Computed Tomography) Scans; Ultrasound; X-Rays

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12651&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Rare Disease Diagnostics Market?

North America was the largest region in the rare disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Rare Disease Diagnostics Market?

The integration of state-of-the-art technology is a leading trend making waves in the rare disease diagnostics market. To maintain their market presence, foremost companies in this sector are harnessing novel technologies. For example, Centogene GmbH, a German firm specializing in rare diseases, introduced CentoGenome, a whole genome sequencing solution to diagnose rare and neurodegenerative diseases, in April 2023. CentoGenome employs an enhanced next-generation sequencing (NGS) assay that provides whole genome sequencing (WGS) tests for a spectrum of rare and neurodegenerative disorders, encompassing nearly all disease-causing variations with a single assay. Additionally, it boasts superior sensitivity for detecting Copy Number Variations (CNVs) related to Spinal Muscular Atrophy (SMA) and complex disease-causing changes associated with Gaucher Disease (GD) and predisposition to GBA1-related Parkinson’s Disease (PD). The application of PCR (polymerase chain reaction)-free technology in hard-to-sequence genomic regions by Centogenome will dramatically decrease bias and provide robust sequencing data, thereby delivering a profound comprehension of coding, regulatory, and intronic regions.

View the full report here:

https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report

What Is the Definition of the Rare Disease Diagnostics Market?

Rare disease diagnostics refers to the process of identifying and diagnosing medical conditions that are considered rare or uncommon. These diagnostics are used for early detection and diagnosis, as well as the selection of targeted and personalized treatment plans for uncommon disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12651

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model